UnitedHealth expanding bundles after positive results

After reporting nearly $18 million in savings for the employers current participating in its bundled payment programs for spinal surgeries and joint replacements, UnitedHealth Group announced it will expand the program to nine additional markets.

While UnitedHealth didn’t disclose the total costs per procedure, it reported $18,000 was saved per procedure for the more than 115 employers in the program. Employees saved more than $3,000 in out-of-pocket costs per procedure for going to a participating facility, driven by the allure of incentives like additional vacation days and cash.

“This program is one example of the ways we are reshaping how health care is delivered, helping enhance care coordination, improve outcomes and deliver greater value,” Sam Ho, MD, chief medical officer of UnitedHealthcare, said in a statement. “The initial results and nationwide expansion demonstrate the value of this program to health care providers, employers and their employees, helping to improve health outcomes and make care more affordable for more people.”

The bundles started with 28 markets in 2016 and will expand to 37 after demonstrating savings as well as improved outcomes. According to UnitedHealth, the spine and joint bundles reduced hospital readmissions by 22 percent and complications by 17 percent for knee and hip replacement patients. For spinal patients, readmissions dropped by 10 percent and there were 3.4 percent fewer complications compared to non-participating facilities.  

UnitedHealth had previously announced its intentions to expand its work on Medicare bundles, including the new Bundled Payments for Care Improvements Advanced model. Commercial insurance has been slower to adopt bundles, as payers waited to see Medicare’s results before jumping in themselves.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.